Or. Admin. R. 851-055-0070
Standards for Prescriptive Authority
Effective Nov 24, 2025ORS 678.150, ORS 678.255, ORS 678.265, ORS 678.275, ORS 678.278, ORS 678.282, ORS 678.285, ORS 678.370, ORS 678.375, ORS 678.372, ORS 678.380 & ORS 678.390 | Statutes/Other Implemented: ORS 678.150, ORS 678.255, ORS 678.265, ORS 678.275, ORS 678.278, ORS 678.282, ORS 678.285, ORS 678.370, ORS 678.375, ORS 678.372, ORS 678.380 & ORS 678.390Board of Nursing
- (1) Prescribing, procuring or authorizing use of controlled substances, non-controlled prescription medications, therapeutic devices, and dispensing drugs must be consistent with the individual’s scope of specialty practice and competency.
- (2) All APRNs who provide pharmacological management for clients must have prescriptive authority.
(3) Prescriptions must be written per the following standards:
- (a) A written prescription must include the date, printed name, legal signature, specialty category/title, business address, and telephone number of the prescribing APRN, in addition to the required client and drug information.
- (b) An electronically transmitted prescription as defined in OAR 855 of the Pharmacy Act must include the name and immediate contact information of the prescriber and be electronically encrypted or in some manner protected by up-to-date technology from unauthorized access, alteration or use. Controlled substances have additional restrictions as defined by the Drug Enforcement Administration (DEA) which must be followed.
- (c) A tamper resistant prescription must meet criteria as defined in OAR 855 of the Pharmacy Act.
- (d) Prescriptions may be written for over-the-counter drugs, durable medical equipment (DME) and therapeutic devices.
- (e) The APRN must comply with all applicable laws and rules in prescribing, administering, and distributing drugs, including compliance with the labeling requirements of ORS 689.
- (f) An APRN must only prescribe controlled substances in conjunction with their own valid and current (DEA) registration number appropriate to the classification level of the controlled substance.
Statutory/Other Authority
ORS 678.150, ORS 678.255, ORS 678.265, ORS 678.275, ORS 678.278, ORS 678.282, ORS 678.285, ORS 678.370, ORS 678.375, ORS 678.372, ORS 678.380 & ORS 678.390
Statutes/Other Implemented
ORS 678.150, ORS 678.255, ORS 678.265, ORS 678.275, ORS 678.278, ORS 678.282, ORS 678.285, ORS 678.370, ORS 678.375, ORS 678.372, ORS 678.380 & ORS 678.390
History
BN 34-2025, temporary amend filed 11/24/2025, effective 11/24/2025 through 12/31/2025
BN 28-2025, amend filed 11/20/2025, effective 11/20/2025
BN 6-2023, amend filed 09/26/2023, effective 10/01/2023
BN 13-2021, adopt filed 06/24/2021, effective 07/01/2021